DK0841930T3 - Stabilt fast præparat af enalaprilsalt og fremgangsmåde til fremstilling deraf - Google Patents

Stabilt fast præparat af enalaprilsalt og fremgangsmåde til fremstilling deraf

Info

Publication number
DK0841930T3
DK0841930T3 DK96925615T DK96925615T DK0841930T3 DK 0841930 T3 DK0841930 T3 DK 0841930T3 DK 96925615 T DK96925615 T DK 96925615T DK 96925615 T DK96925615 T DK 96925615T DK 0841930 T3 DK0841930 T3 DK 0841930T3
Authority
DK
Denmark
Prior art keywords
enalapril
solid composition
preparation
stable solid
water
Prior art date
Application number
DK96925615T
Other languages
English (en)
Inventor
Bernard Charles Sherman
Original Assignee
Bernard Charles Sherman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24034300&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0841930(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bernard Charles Sherman filed Critical Bernard Charles Sherman
Application granted granted Critical
Publication of DK0841930T3 publication Critical patent/DK0841930T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401Proline; Derivatives thereof, e.g. captopril
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55Protease inhibitors
    • A61K38/556Angiotensin converting enzyme inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
DK96925615T 1995-08-04 1996-07-30 Stabilt fast præparat af enalaprilsalt og fremgangsmåde til fremstilling deraf DK0841930T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/511,297 US5573780A (en) 1995-08-04 1995-08-04 Stable solid formulation of enalapril salt and process for preparation thereof
EP96925615A EP0841930B1 (en) 1995-08-04 1996-07-30 Stable solid formulation of enalapril salt and process for preparation thereof
PCT/CA1996/000513 WO1997005881A1 (en) 1995-08-04 1996-07-30 Stable solid formulation of enalapril salt and process for preparation thereof

Publications (1)

Publication Number Publication Date
DK0841930T3 true DK0841930T3 (da) 2005-04-25

Family

ID=24034300

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96925615T DK0841930T3 (da) 1995-08-04 1996-07-30 Stabilt fast præparat af enalaprilsalt og fremgangsmåde til fremstilling deraf

Country Status (14)

Country Link
US (2) US5573780A (da)
EP (4) EP1527780A1 (da)
JP (1) JP3290994B2 (da)
AT (1) ATE288271T1 (da)
AU (1) AU697696C (da)
BR (1) BR9609964A (da)
CA (1) CA2166001C (da)
DE (4) DE04076118T1 (da)
DK (1) DK0841930T3 (da)
ES (4) ES2264912T1 (da)
IL (1) IL123185A (da)
NZ (1) NZ313576A (da)
RU (1) RU2161970C2 (da)
WO (1) WO1997005881A1 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5573780A (en) * 1995-08-04 1996-11-12 Apotex Usa Inc. Stable solid formulation of enalapril salt and process for preparation thereof
ES2125198B1 (es) * 1997-05-13 1999-11-16 Vita Invest Sa Asociacion a dosis fija de un inhibidor de la enzima convertidora de angiotensina y de un antagonista de los canales de calcio, procedimiento para su preparacion y su utilizacion para el tratamiento de enfermees cardiovasculares.
US6296871B1 (en) * 1998-04-12 2001-10-02 Ranbaxy Laboratories Limited Stable solid pharmaceutical compositions containing enalapril maleate
US6153223A (en) * 1998-06-05 2000-11-28 Watson Pharmaceuticals, Inc. Stabilized pharmaceutical compositions
NZ333206A (en) * 1998-12-08 2000-07-28 Bernard Charles Sherman Solid pharmaceutical compositions comprising a stable magnesium salt of quinapril that acts as a ACE (Angiotensin Converting Enzyme) inhibitor
US6637359B1 (en) * 1998-12-15 2003-10-28 Maritrans Inc. System and method for internally fitting a new inner hull to an existing outer hull to form a rebuilt double hull vessel
US6764694B1 (en) * 1999-08-31 2004-07-20 Mutual Pharmaceutical Co., Inc. Stable formulations of ACE inhibitors, and methods for preparation thereof
US20040157911A1 (en) * 1999-08-31 2004-08-12 Spiridon Spireas Storage-stable and bio-stable formulations of ace inhibitors, and methods for preparation thereof
US6555551B1 (en) 1999-08-31 2003-04-29 Mutual Pharmaceutical Co., Inc. Stable formulations of ACE inhibitors, and methods for preparation thereof
US20030225124A1 (en) * 1999-08-31 2003-12-04 Spiridon Spireas Stable formulations of ACE inhibitors, and methods for preparation thereof
US20050118259A1 (en) * 2002-01-15 2005-06-02 Renir Eyjolfsson Formulations of quinapril and related ace nhibitors
US20030215526A1 (en) * 2002-03-08 2003-11-20 Scott Stofik Stable formulations of angiotensin converting enzyme (ACE) inhibitors
RS53324B (en) 2005-11-17 2014-10-31 Silverstone Pharma Est. STABLE FORMULATION OF AMORPHIC SALES OF PERINDOPRIL, PROCEDURE FOR THEIR PREPARATION, IN PARTICULAR INDUSTRIAL PREPARATION, AND THEIR USE IN HYPERTENSION THERAPY
EP2585051B2 (en) 2010-06-23 2020-04-08 KRKA, tovarna zdravil, d.d., Novo mesto Pharmaceutical oral dosage forms comprising lercanidipine and enalapril and their pharmaceutically acceptable salts
EP2654729B1 (en) 2010-12-24 2016-05-04 KRKA, d.d., Novo mesto Homogenous pharmaceutical oral dosage forms comprising lercanidipine and enalapril or their pharmaceutically acceptable salts together with an organic acid
CN109350733A (zh) * 2018-06-08 2019-02-19 山东理工职业学院 一种马来酸依那普利片剂的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL58849A (en) * 1978-12-11 1983-03-31 Merck & Co Inc Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them
US4743450A (en) * 1987-02-24 1988-05-10 Warner-Lambert Company Stabilized compositions
YU48602B (sh) * 1991-11-25 1998-12-23 Krka Tovarna Zdravil P.O. Postupak za dobijanje stabilne formulacije soli enalaprila
WO1994001093A1 (en) * 1992-07-09 1994-01-20 Merck & Co., Inc. Controlled porosity osmotic enalapril pump
US5573780A (en) * 1995-08-04 1996-11-12 Apotex Usa Inc. Stable solid formulation of enalapril salt and process for preparation thereof

Also Published As

Publication number Publication date
EP0841930B1 (en) 2005-02-02
DE04076118T1 (de) 2005-02-10
US5690962A (en) 1997-11-25
NZ313576A (en) 1999-05-28
EP1637142A2 (en) 2006-03-22
BR9609964A (pt) 1999-02-02
DE05076813T1 (de) 2006-11-30
EP1637142A3 (en) 2008-04-02
ATE288271T1 (de) 2005-02-15
DE69616072T2 (de) 2009-09-10
EP0841930A1 (en) 1998-05-20
DE04078149T1 (de) 2005-12-29
RU2161970C2 (ru) 2001-01-20
EP1527780A1 (en) 2005-05-04
JP3290994B2 (ja) 2002-06-10
ES2236741T3 (es) 2005-07-16
AU6608496A (en) 1997-03-05
AU697696B2 (en) 1998-10-15
IL123185A0 (en) 1998-09-24
JPH10511103A (ja) 1998-10-27
CA2166001C (en) 2005-12-27
ES2264912T1 (es) 2007-02-01
ES2245275T1 (es) 2006-01-01
WO1997005881A1 (en) 1997-02-20
EP1442746A1 (en) 2004-08-04
AU697696C (en) 2006-04-06
DE69616072D1 (de) 2001-11-22
US5573780A (en) 1996-11-12
ES2223315T1 (es) 2005-03-01
IL123185A (en) 2001-08-08
CA2166001A1 (en) 1996-12-05

Similar Documents

Publication Publication Date Title
DK0841930T3 (da) Stabilt fast præparat af enalaprilsalt og fremgangsmåde til fremstilling deraf
TR200000832A2 (tr) Sıkıştırılmış kalıp cisimleri için yoğunlaştırılmış patlayıcı taneler.
DK0774949T3 (da) Klæbemiddel til tandproteser
DK0547165T3 (da) Fremgangsmåde til fremstilling af vandopløselige camptothecinanaloger såvel som forbindelserne 10-hydroxy-11-C(1-6)-alkoxyc
TR199902773A2 (xx) S�k��t�r�lm�� gran�l, �retimi ve sulama maddesi olarak kullan�m�.
ES2053470T3 (es) Preparados farmaceuticos de liberacion retardada.
DE58900594D1 (de) Ibuprofen-brausezubereitungen.
IE871730L (en) Calcium compositions
RU98103239A (ru) Стабильная твердая фармацевтическая композиция на основе соли эналаприла и способ ее приготовления
DE3883098T2 (de) Sprühgetrocknete Ibuprofen-Zusammensetzungen.
NO990908L (no) Br°nnbetjeningsfluider
JPS53121891A (en) Preparation of methyl methacrylate polymer
NO990665L (no) Granulater omfattende en vannl°selig forbindelse og cellulose
EP0107086A3 (en) Concrete set modification with encapsuled surfactant
ATE275577T1 (de) Quinapril magnesium enthaltende, pharmazeutisch wirksame zusammensetzung
DK0773783T3 (da) Fremstilling af fusidinsyretabletter
DK1117365T3 (da) Vedhæftningsmiddel til tandproteser
JPS53121892A (en) Preparation of methyl methacrylate polymer
RU99107824A (ru) Композиция для таблетирования и способ приготовления таблеток
JPS55122713A (en) Tablet comprising antibacterial substance
BR9813873A (pt) Base efervescente
RU98100629A (ru) Состав для регулирования проницаемости пласта и изоляции водопритоков
JPS51117347A (en) Sawdust boiler
JPS56150028A (en) Preparation of vinylidene halide
RU94046203A (ru) Способ получения 5-дихлорацетил-3,3,6-триметил-9-оксо-1,5-диазабицикло[4,3,0]нонана